Skip to main content

Pathway Genomics Partners with Colombian Lab on Genetic Testing

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pathway Genomics has partnered with the Instituto de Referencia Andino (IRA), a clinical lab division of Rochem Biocare, to offer Pathway's personal genetic health and ancestry testing to residents of Latin America.

IRA is a high-complexity lab based in Bogota, Colombia, with 200 affiliate labs in Colombia, Ecuador, and Peru.

In addition to offering Pathway's tests, the firms will collaborate on identifying genetic markers linked to common health conditions in Latin and Hispanic populations. The markers will then be used by Pathway to further tailor its custom-designed DNA genotyping technology, enabling it to offer genetic testing to the broader Latin American populations, it said.

"By providing access to residents of Latin America we can expand our services into new communities, helping more people learn about the benefits of personal genetic testing," Jim Woodman, VP of business development for San Diego-based Pathway, said in a statement.

Financial and other terms of the alliance were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.